HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Correction: HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer.

Abstract
[This corrects the article DOI: 10.18632/oncotarget.19019.].
AuthorsTeru Hideshima, Ralph Mazitschek, Jun Qi, Naoya Mimura, Jen-Chieh Tseng, Andrew L Kung, James E Bradner, Kenneth C Anderson
JournalOncotarget (Oncotarget) Vol. 12 Issue 17 Pg. 1736 (Aug 17 2021) ISSN: 1949-2553 [Electronic] United States
PMID34434504 (Publication Type: Published Erratum)
CopyrightCopyright: © 2021 Hideshima et al.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: